Accurate reporting of HER2 (ERBB2) gene copy number status in newly diagnosed breast and gastric cancers is critical for selecting patients predicted to respond to anti-HER2 therapy. Reading the story of how targeted HER2 therapies were developed and how they positively impact patients with breast cancer brings home the importance of this testing. In current…
Read more
About: pdx_admin
Recent Posts by pdx_admin
HER2 testing by Micro-array, resolving tough diagnostic questions
Accurate reporting of HER2 (ERBB2) gene copy number status in newly diagnosed breast and gastric cancers is critical for selecting patients predicted to respond to anti-HER2 therapy. In current clinical practice, tumors are evaluated for HER2 positivity by protein-based immunohistochemistry (IHC) and/or chromosome 17-based fluorescence in situ hybridization (FISH). In the majority of cases, these…
Read more
Recent Comments by pdx_admin
No comments by pdx_admin yet.